These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 23155275)
1. c-MYC amplification in mucinous gastric carcinoma: a possible genetic alteration leading to deeply invasive tumors. Choi JS; Seo J; Jung EJ; Kim EJ; Lee GK; Kim WH Anticancer Res; 2012 Nov; 32(11):5031-7. PubMed ID: 23155275 [TBL] [Abstract][Full Text] [Related]
2. Mucinous gastric carcinomas: clinicopathologic and molecular analyses. Choi JS; Kim MA; Lee HE; Lee HS; Kim WH Cancer; 2009 Aug; 115(15):3581-90. PubMed ID: 19479974 [TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor receptor 2 gene amplification status and its clinicopathologic significance in gastric carcinoma. Jung EJ; Jung EJ; Min SY; Kim MA; Kim WH Hum Pathol; 2012 Oct; 43(10):1559-66. PubMed ID: 22440694 [TBL] [Abstract][Full Text] [Related]
4. Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target. Lee J; Seo JW; Jun HJ; Ki CS; Park SH; Park YS; Lim HY; Choi MG; Bae JM; Sohn TS; Noh JH; Kim S; Jang HL; Kim JY; Kim KM; Kang WK; Park JO Oncol Rep; 2011 Jun; 25(6):1517-24. PubMed ID: 21424128 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic characteristics and prognosis of mucinous gastric carcinoma. Zhang M; Zhu GY; Zhang HF; Gao HY; Han XF; Xue YW J Surg Oncol; 2010 Jul; 102(1):64-7. PubMed ID: 20578080 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma. Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H Ann Surg Oncol; 2006 Jun; 13(6):836-42. PubMed ID: 16604474 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction. Kim MA; Jung EJ; Lee HS; Lee HE; Jeon YK; Yang HK; Kim WH Hum Pathol; 2007 Sep; 38(9):1386-93. PubMed ID: 17555797 [TBL] [Abstract][Full Text] [Related]
9. Gene amplification of ribosomal protein S6 kinase-1 and -2 in gastric cancer. Yoshida S; Matsumoto K; Arao T; Taniguchi H; Goto I; Hanafusa T; Nishio K; Yamada Y Anticancer Res; 2013 Feb; 33(2):469-75. PubMed ID: 23393338 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic study of early-stage mucinous gastric carcinoma. Adachi Y; Yasuda K; Inomata M; Shiraishi N; Kitano S; Sugimachi K Cancer; 2001 Feb; 91(4):698-703. PubMed ID: 11241236 [TBL] [Abstract][Full Text] [Related]
11. Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas. Robanus-Maandag EC; Bosch CA; Kristel PM; Hart AA; Faneyte IF; Nederlof PM; Peterse JL; van de Vijver MJ J Pathol; 2003 Sep; 201(1):75-82. PubMed ID: 12950019 [TBL] [Abstract][Full Text] [Related]
12. Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma. Liang PI; Wu LC; Sheu JJ; Wu TF; Shen KH; Wang YH; Wu WR; Shiue YL; Huang HY; Hsu HP; Chen YH; Chen LT; Li CF; Liao AC J Clin Pathol; 2012 Sep; 65(9):802-7. PubMed ID: 22685262 [TBL] [Abstract][Full Text] [Related]
13. MYC quantitation in cell-free plasma DNA by real-time PCR for gastric cancer diagnosis. Park KU; Lee HE; Park DJ; Jung EJ; Song J; Kim HH; Choe G; Kim WH; Lee HS Clin Chem Lab Med; 2009; 47(5):530-6. PubMed ID: 19302034 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic features of mucinous gastric carcinoma. Lim SW; Kim DY; Kim YJ; Kim SK Dig Surg; 2002; 19(4):286-90. PubMed ID: 12207072 [TBL] [Abstract][Full Text] [Related]
15. Relations of the c-myc gene and chromosome 8 in non-small cell lung cancer: analysis by fluorescence in situ hybridization. Kubokura H; Tenjin T; Akiyama H; Koizumi K; Nishimura H; Yamamoto M; Tanaka S Ann Thorac Cardiovasc Surg; 2001 Aug; 7(4):197-203. PubMed ID: 11578259 [TBL] [Abstract][Full Text] [Related]
16. A clinicopathologic study of mucinous gastric carcinoma including multivariate analysis. Wu CY; Yeh HZ; Shih RT; Chen GH Cancer; 1998 Oct; 83(7):1312-8. PubMed ID: 9762931 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer. Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329 [TBL] [Abstract][Full Text] [Related]
18. Is the presence of distant metastasis associated with c-myc amplification in gastric cancer? Hajdú J; Kozma L; Kiss I; Szentkereszty Z; Szakáll S; Ember I Acta Chir Hung; 1997; 36(1-4):119-21. PubMed ID: 9408311 [TBL] [Abstract][Full Text] [Related]
19. Aneuploidy of chromosome 8 and C-MYC amplification in individuals from northern Brazil with gastric adenocarcinoma. Calcagno DQ; Leal MF; Taken SS; Assumpção PP; Demachki S; Smith Mde A; Burbano RR Anticancer Res; 2005; 25(6B):4069-74. PubMed ID: 16309200 [TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization analysis of c-myc amplification in stage TNM prostate cancer in Japanese patients. Sato H; Minei S; Hachiya T; Yoshida T; Takimoto Y Int J Urol; 2006 Jun; 13(6):761-6. PubMed ID: 16834657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]